Mark Hillman Hillman Capital Management
Mark Hillman is associated with Hillman Capital Management, a firm focused on fundamental equity research and long-term portfolio management. The firm’s public filings are followed by investors interested in actively managed, research-driven U.S. equity exposure. Hillman’s process emphasizes business analysis and valuation discipline rather than short-term trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FISV
Fiserv Inc
FISV
|
+$2.62M |
| 2 |
Oracle
ORCL
|
+$2.62M |
| 3 |
Adobe
ADBE
|
+$2.47M |
| 4 |
Zimmer Biomet
ZBH
|
+$893K |
| 5 |
Brown-Forman Class B
BF.B
|
+$762K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$5.89M |
| 2 |
AB InBev
BUD
|
+$5.29M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.55M |
| 4 |
Akamai
AKAM
|
+$920K |
| 5 |
GSK
GSK
|
+$916K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.08% |
| 2 | Consumer Staples | 18.33% |
| 3 | Technology | 15.93% |
| 4 | Communication Services | 9.78% |
| 5 | Materials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Biogen
BIIB
$32B
| $5.42M | 3.76% |
29,540
-976
| -3% | -$180K |
|
2
DuPont de Nemours
DD
$18.7B
| $5.4M | 3.75% |
39,300
-5,116
| -12% | -$706K |
|
3
Warner Bros
WBD
$71.6B
| $5.39M | 3.74% |
196,309
-18,291
| -9% | -$512K |
|
|
4
GSK
GSK
$105B
| $5.38M | 3.73% |
97,432
-16,904
| -15% | -$916K |
|
5
International Flavors & Fragrances
IFF
$21.5B
| $5.28M | 3.67% |
72,773
-3,258
| -4% | -$239K |
|
6
Pfizer
PFE
$160B
| $5.28M | 3.66% |
187,937
+12,633
| +7% | +$336K |
|
|
7
Zimmer Biomet
ZBH
$19.3B
| $5.04M | 3.5% |
55,700
+9,731
| +21% | +$893K |
|
8
CVS Health
CVS
$119B
| $4.85M | 3.36% |
67,462
-4,223
| -6% | -$325K |
|
|
9
Brown-Forman Class B
BF.B
$13.1B
| $4.66M | 3.24% |
176,437
+28,385
| +19% | +$762K |
|
10
CarMax
KMX
$8.82B
| $4.54M | 3.15% |
109,181
-1,907
| -2% | -$83.5K |
|
11
Kraft Heinz
KHC
$30.3B
| $4.52M | 3.14% |
201,140
+24,333
| +14% | +$572K |
|
|
FISV
12
Fiserv Inc
FISV
$28B
| $4.5M | 3.13% |
80,728
+42,352
| +110% | +$2.62M |
|
13
Boeing
BA
$169B
| $4.44M | 3.09% |
22,326
-3,101
| -12% | -$706K |
|
14
Baxter International
BAX
$13.6B
| $4.15M | 2.89% |
247,320
+35,779
| +17% | +$692K |
|
15
Nike
NKE
$60.5B
| $4.11M | 2.86% |
77,906
+9,766
| +14% | +$592K |
|
16
Microsoft
MSFT
$3.59T
| $4.01M | 2.78% |
10,828
+243
| +2% | +$102K |
|
|
17
Adobe
ADBE
$109B
| $3.94M | 2.73% |
16,200
+8,931
| +123% | +$2.47M |
|
18
Estee Lauder
EL
$36.9B
| $3.74M | 2.6% |
52,172
-2,631
| -5% | -$269K |
|
19
Campbell Soup
CPB
$7.14B
| $3.7M | 2.57% |
166,178
+25,494
| +18% | +$655K |
|
20
Verizon
VZ
$205B
| $3.26M | 2.27% |
64,998
-179
| -0.3% | -$8.3K |
|
21
Bristol-Myers Squibb
BMY
$137B
| $3.22M | 2.24% |
53,102
-864
| -2% | -$50.4K |
|
22
iShares MSCI EAFE ETF
EFA
$80B
| $3M | 2.08% |
30,854
+2,292
| +8% | +$229K |
|
23
Constellation Brands
STZ
$23.2B
| $2.82M | 1.96% |
18,795
+775
| +4% | +$120K |
|
24
Comcast
CMCSA
$95.3B
| $2.73M | 1.9% |
95,228
+4,367
| +5% | +$131K |
|
25
US Bancorp
USB
$96.7B
| $2.73M | 1.9% |
52,528
-765
| -1% | -$42K |
|
Similar funds
Mark Hillman's Q1 2026 Portfolio in Review
As of Q1 2026, Mark Hillman held 62 positions worth $144M, down 9.4% from $159M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Mark Hillman withdrew a net $7.47M in Q1 2026, closing 6 positions and reducing 23 holdings. Its most notable exit was ASML, an estimated $5.89M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Consumer Staples and Technology.
Against the trend, Mark Hillman opened a new position in Oracle worth $2.37M.
- Mark Hillman's largest Q1 2026 buy was Oracle: 16,109 shares worth $2.37M.
- Mark Hillman added most to Fiserv Inc in Q1 2026, an estimated $2.62M increase.
- Mark Hillman's biggest Q1 2026 reduction was Akamai, cutting an estimated $920K.
- Mark Hillman fully exited ASML in Q1 2026, selling an estimated $5.89M.
- Mark Hillman's ten largest holdings make up 36% of its $144M portfolio in Q1 2026.
- Mark Hillman opened 6 new positions and closed 6 in Q1 2026.
- Mark Hillman's portfolio value fell 9.4% quarter-over-quarter to $144M.
Based on Hillman Capital Management's 13F filing for Q1 2026, filed 15 May 2026.